- Visibility 394 Views
- Downloads 396 Downloads
- Permissions
- DOI 10.18231/j.ijos.2025.027
-
CrossMark
Atypical femur fractures: A case series study from a tertiary care hospital in urban India
- Author Details:
-
Arun Padmanandan
-
Pushkar Chawla
-
Ritabh Kumar *
-
Mansi Sharma
Arun Padmanandan
Anti-osteoporosis medications have led to a significant improvement in the quality of life of the elderly. Amongst them, bisphosphonate therapy has reported the most impressive outcomes in terms of reduction in the incidence of fractures. With increasing use of the drugs an association was reported from Asian countries with low energy femur fractures. The cause for a higher incidence of such low energy atypical femur fractures in Asian population could be due to genetic variances in bone remodelling and bisphosphonate metabolism, a higher incidence of osteomalacia (Vitamin D deficiency), or a tendency for increased femoral bowing resulting in accumulation of localized cortical stresses. From 2020 to 2023, we studied 19 cases of atypical femur fractures that presented to our trauma unit. Most of the patients had unilateral pathology. A diligent search for the pathology on the contralateral side was positive in only 3 of the 19 patients. Five patients did not report the use of bisphosphonates. Spontaneous onset of some unease or discomfort in the thigh in the elderly females must not be ignored. Intramedullary femoral nail seems to be the most effective treatment strategy. Prophylactic nailing must be recommended to avoid progression to complete fracture.
Keywords: Atypical femur fractures, Bisphosphonates, Prophylactic femur nailing.
References
- Wells GA, Cranney A, Peterson J. Alendronate for primary and secondary prevention of osteoporotic fractures in post- menopausal woman. Cochrane Database Syst Rev. 2008;1:CD001155.
- Geissler JR, Bajaj D, Fritton JC. Cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical femur fractures. J Biomech. 2015;48(6):883–94.
- Kharwadkar N, Mayne B, Lawrence JE, Khanduja V. Bisphosphonates and atypical subtrochanteric fractures of femur. Bone Joint Res. 2017;6(3):144–53.
- Kang JS, Won YY, Kim JO. Atypical femoral fractures after anti- osteoporotic medications- a Korean multicenter study. Int Orthop. 2014;38(6):1247–53.
- Schilcher J, Howe TS, Png MA, Aspenberg P, Koh JSB. Atypical femur fractures are mainly subtrochanteric in Singapore and diaphyseal in Sweden- a cross sectional study. J Bone Miner Res. 2015;30(11):2127–32.
- Lee YK, Ahn S, Kim KM, Suh CS, Koo KH. Incidence rate of atypical femoral fracture after bisphosphonates treatment in Korea. J Korean Med Sci. 2018;33(5):e38.
- Oh Y, Yamamoto K, Hashimoto J. Biological activity is not suppressed in mid shaft stress fractures of the bowed femoral shaft unlike in “typical’’ atypical sub-trochanteric femoral fracture: a proposed theory of atypical femoral fracture sub-types. Bone. 2020;137:115453.
- Haider IT, Schneider PS, Edwards WB. The role of lower limb geometry in the pathophysiology of atypical femoral fractures. Curr Osteoporos Rep. 2019;17(5):281–90.
- Harborne K, Hazlehurst JM, Shanmugaratnam H, Pearson S, Doyle A, Gittoes NJ et al. Compliance with established guidelines for the radiological reporting of atypical femoral fractures. Br J Radiol. 2016;89(1057):20150443.
- Yates CJ, Bartlett MJ, Ebeling PR. An atypical subtrochanteric femoral fracture from pycnodysostosis. J Bone Miner Res. 2011;26(6):1377–9.
- Whyte MP. Atypical femur fractures, Bisphosphonates, hypophospatasia. J Bone Miner Res. 2009;24(6):1132–4.
- Kim S, Bang HH, Yoo H, Park IH, Yang KH, Lim H, et al. Difference in bone mineral density change at the lateral femoral cortices according to administration of different bisphosphonate agents. J Bone Metab. 2016;23(2):85-93.
- Juby AG, Crowther S, Cree M. Identifying Atypical Femoral fractures- A retrospective review. Calcif Tissue Int. 2014;95(5):405–12.
- Egol KA, Bronson WH, Kaye ID. Atypical femur fractures- a review. Curr Osteoporos Rep. 2014;12(4):446–53.
- Koh A, Guerado E, Gainnoudis PV. Atypical femur fractures related to bisphosphonate treatment. Bone Joint J. 2017;99- B(3):295–302.